Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Buy

A

Terns Pharmaceuticals, Inc. Common Stock (TERN)

Pharmaceutical Preparations

https://www.ternspharma.com

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

1065 EAST HILLSDALE BLVD., SUITE 100
FOSTER CITY, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/05/2021

Market Cap

510,899,994

Shares Outstanding

61,800,000

Weighted SO

61,794,522

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

AMLX --.--%

ABOS --.--%

INZY --.--%

XFOR --.--%

MREO --.--%

PDSB --.--%

HOOK --.--%

DAWN --.--%

ELDN --.--%

Beta

-0.3810

Last Div

0.0000

Range

3.26-10.03

Chg

0.5400

Avg Vol

1221922

Mkt Cap

510899994

Exch

NASDAQ

Country

US

Phone

650 525 5535

DCF Diff

6.0368

DCF

1.1132

Div Yield

0.0000

P/S

386.4599

EV Multiple

-3.9108

P/FV

2.4720

Div Yield %

0.0000

P/E

-5.6372

PEG

-0.2354

Payout

0.0000

Current Ratio

21.0167

Quick Ratio

21.0167

Cash Ratio

8.3520

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

744.7113

CCC

-744.7113

Gross Margin

0.3056

Op Margin

-81.8646

Pretax Margin

-72.3374

Net Margin

-72.5378

Eff Tax Rate

-0.0028

ROA

-0.4153

ROE

-0.3958

ROCE

-0.4921

NI/EBT

1.0028

EBT/EBIT

0.8836

EBIT/Rev

-81.8646

Debt Ratio

0.0011

D/E

0.0011

LT Debt/Cap

0.0000

Total Debt/Cap

0.0011

Int Coverage

-42.1273

CF/Debt

-317.2369

Equity Multi

1.0558

Rec Turnover

0.0000

Pay Turnover

0.4901

Inv Turnover

0.0000

FA Turnover

2.2521

Asset Turnover

0.0057

OCF/Share

-1.0609

FCF/Share

-1.0621

Cash/Share

3.0258

OCF/Sales

-59.7519

FCF/OCF

1.0012

CF Coverage

-317.2369

ST Coverage

-317.2369

CapEx Coverage

-840.3404

Div&CapEx Cov

-840.3404

P/BV

2.4720

P/B

2.4720

P/S

386.4599

P/E

-5.6372

P/FCF

-6.4601

P/OCF

-6.8435

P/CF

-6.8435

PEG

-0.2354

P/S

386.4599

EV Multiple

-3.9108

P/FV

2.4720

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Sep 14, 14:12 1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More GlobeNewswire Inc. Sep 11, 02:50 Terns Announces Pricing of Upsized $150.15 Million Public Offering GlobeNewswire Inc. Jun 21, 22:30 Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation

Revenue Product Segmentation